Gene Therapy ‘Survival Of The Fittest’ – Why Companies Need To Understand Health Systems

Cell and gene therapy manufacturers must consider the practicalities of their product within the context of a health care system before it comes onto the market to be successful, experts from Novartis, AstraZeneca and England’s National Health Service say.